retatrutide weight loss phase 2 trial results just delivered one of the largest weight-loss signals we've ever seen in a medication trial. In a study: • Up to 24.2% mean at 48 weeks Retatrutide Delivers Bariatric-Level Weight Loss

Commercial products marketed as GLP-1 patches do not contain real GLP-1 medication and should not be considered safe or effective treatments

As soon as the peptide is dissolved, it goes straight back into the refrigerator

He et al

placebo), most of them (liraglutide, semaglutide SC, dulaglutide, albiglutide, and efpeglenatide) have also demonstrated a reduction in MACE with respect to placebo, while weekly exenatide or oral semaglutide showed a tendency to reduce MACE

Effects of SGLT2 inhibitors on fractures and bone mineral density in type 2 diabetes mellitus: an updated meta-analysis

The cost per pound of weight loss often makes these medications more economical than many realize when compared to repeated failed diet attempts, gym memberships, supplements, and weight loss programs